• Login
    View Item 
    •   Home
    • Nottinghamshire Healthcare NHS Foundation Trust
    • Conditions and Diseases
    • Mental Health and Behavioural Conditions
    • Bipolar Disorder
    • View Item
    •   Home
    • Nottinghamshire Healthcare NHS Foundation Trust
    • Conditions and Diseases
    • Mental Health and Behavioural Conditions
    • Bipolar Disorder
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of EMERCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjectsProfilesView

    My Account

    LoginRegister

    Links

    About EMERPoliciesDerbyshire Community Health Services NHS Foundation TrustLeicester Partnership TrustNHS Nottingham and Nottinghamshire CCGNottinghamshire Healthcare NHS Foundation TrustNottingham University Hospitals NHS TrustSherwood Forest Hospitals NHS Foundation TrustUniversity Hospitals of Derby and Burton NHS Foundation TrustUniversity Hospitals Of Leicester NHS TrustOther Resources

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    NICE guidance: Why not clozapine for treatment-refractory bipolar disorder? - Authors' reply

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Morriss, Richard K.
    Keyword
    Bipolar disorder
    Date
    2016
    
    Metadata
    Show full item record
    DOI
    10.1016/S2215-0366(16)30098-0
    Publisher's URL
    http://www.sciencedirect.com/science/article/pii/S2215036616300980
    Abstract
    Comments on an article by Tarun Bastiampillai et al. (see record 2016-28928-015). Tarun Bastiampillai and colleagues for their Correspondence. There is no consensus on the definition of "treatment-resistant bipolar disorder". Some people who failed to respond to previous therapies were included in trials we considered in the UK National Institute for Health and Care Excellence (NICE) guideline. We did not exclude trials that included only people who failed to respond to previous treatments. It is unclear whether Bastiampillai and colleagues advocate the use of clozapine for the treatment of particular bipolar disorder episodes (ie, mania or depression) or for long term management, which were considered separately in the guideline. There are randomized controlled trials of treatments for all phases of bipolar disorder, and the NICE guideline recommends the treatments supported by rigorous evidence of effectiveness and safety. NICE has recommended clozapine for treatment-resistant schizophrenia in the psychosis and schizophrenia guideline. (PsycINFO Database Record (c) 2016 APA, all rights reserved)
    Citation
    Morriss, R. K., Mayo-Wilson, E. & Kendall, T. (2016). NICE guidance: Why not clozapine for treatment-refractory bipolar disorder? - Authors' reply. The Lancet Psychiatry, 3 (6), pp.503.
    Type
    Correspondence
    URI
    http://hdl.handle.net/20.500.12904/12224
    Collections
    Bipolar Disorder

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.